[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359599-105":59,"doc-detail-359599-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-value-of-peripheral-blood-fibrinogen-to-albumin-ratio-in-pancreatic-cancer-patients-a-systematic-review-and-meta-analysis","Prognostic value of peripheral blood fibrinogen-to-albumin ratio in pancreatic cancer patients - a systematic review and meta-analysis","","Pancreatic cancer is a highly lethal malignancy with poor outcomes driven by late diagnosis and limited treatment efficacy, making reliable prognostic biomarkers essential for individualized management. This systematic review and meta-analysis evaluates the fibrinogen-to-albumin ratio (FAR) as a marker of systemic inflammation and nutritional status by synthesizing studies reporting hazard ratios for overall survival or progression-free survival. Searches cover PubMed, Scopus, EMBASE, and the Cochrane Library up to September 2025.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-value-of-peripheral-blood-fibrinogen-to-albumin-ratio-in-pancreatic-cancer-patients-a-systematic-review-and-meta-analysis/359599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-value-of-peripheral-blood-fibrinogen-to-albumin-ratio-in-pancreatic-cancer-patients-a-systematic-review-and-meta-analysis/359599.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the review?","Question",{"text":112,"@type":113},"To determine whether the peripheral blood fibrinogen-to-albumin ratio (FAR) can predict prognosis in pancreatic cancer patients by synthesizing available studies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the studies searched and selected?",{"text":117,"@type":113},"The review searched PubMed, Scopus, EMBASE, and the Cochrane Library up to September 2025 and included eligible studies reporting hazard ratios for overall survival or progression-free survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results show about high FAR?",{"text":121,"@type":113},"High FAR was significantly associated with worse overall survival and shorter progression-free survival, with supportive sensitivity and publication bias assessments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359599,1790618254,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Lu et al. BMC Cancer (2026) 26:482 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15840-7](https://doi.org/10.1186/s12885-026-15840-7)  \nRESEARCH Open Access  \nPrognostic value of peripheral blood fibrinogen-to-albumin ratio in pancreatic cancer patients: a systematic review and meta-analysis  \nJingjing Lu1, Cuilin Yuan1, Jianfeng Pan1 and Zonghan Xiang2*  \nAbstract  \nBackground Pancreatic cancer (PC) is a highly lethal malignancy with poor prognosis, largely due to late diagnosis and limited therapeutic efficacy. Identifying accessible and reliable prognostic biomarkers is essential for individualized patient management. The fibrinogen-to-albumin ratio (FAR) has emerged as a potential indicator reflecting systemic inflammation and nutritional status.  \nMethods We performed a systematic review and meta-analysis of studies assessing FAR in PC patients. Databases including PubMed, Scopus, EMBASE, and the Cochrane Library were searched up to September 2025. Eligible studies reported hazard ratios (HRs) for overall survival (OS) or progression-free survival (PFS) . Pooled analyses, subgroup evaluations, sensitivity tests, and publication bias assessments were conducted using standard meta-analytic techniques.  \nResults Six retrospective studies encompassing 1,295 patients were included. High FAR was significantly associated with worse OS (HR = 2 . 26; 95% CI: 1.73–2. 96; p \u003C 0. 001) and shorter PFS (HR = 1 . 88; 95% CI: 1.34–2. 66; p \u003C 0. 001) . Subgroup analyses confirmed the prognostic value of FAR across different treatment modalities and cut-off thresholds. Sensitivity analyses and publication bias tests supported the robustness of these findings.  \nConclusions High FAR is a simple, cost-effective, and reproducible biomarker predicting poor survival in PC, integrating tumor-related inflammation and host nutritional status. FAR may aid in risk stratification and individualized management, though prospective, multicenter studies are needed to validate its clinical utility and clarify underlying mechanisms.  \nKeywords Pancreatic cancer, Prognosis, Fibrinogen-to-albumin ratio  \n*Correspondence:  \nZonghan Xiang  \n[honghong140326@163.com](honghong140326@163.com)  \n1Department of Gastroenterology, Hangzhou Xiaoshan Hospital of Traditional Chinese Medicine, Jiangnan Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 311201, China  \n2Department of Oncology, Hangzhou Xiaoshan Hospital of Traditional Chinese Medicine, Jiangnan Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 311201, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLu et al. BMC Cancer (2026) 26:482  \nIntroduction  \nPancreatic cancer (PC) remains one of the most devastating human malignancies, defined by a covert onset, rapid clinical progression, and extremely limited therapeutic efficacy. Among all cancer types, PC exhibits the most dismal outcome","cbCaifcSMPqLg7Am","https://ap.wps.com/l/cbCaifcSMPqLg7Am","pdf",2422280,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main objective of the review?\",\"answer\":\"To determine whether the peripheral blood fibrinogen-to-albumin ratio (FAR) can predict prognosis in pancreatic cancer patients by synthesizing available studies.\"},{\"question\":\"How were the studies searched and selected?\",\"answer\":\"The review searched PubMed, Scopus, EMBASE, and the Cochrane Library up to September 2025 and included eligible studies reporting hazard ratios for overall survival or progression-free survival.\"},{\"question\":\"What do the results show about high FAR?\",\"answer\":\"High FAR was significantly associated with worse overall survival and shorter progression-free survival, with supportive sensitivity and publication bias assessments.\"}]","Prognostic value of peripheral blood fibrinogen-to-albumin ratio in pancreatic cancer patients - a systematic review and meta-analysis | PDF",1790137248,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/158a9e2d9e2dec1b910c18835d1a738d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d975d6c57cb8c8a8936da6047f69675.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aece4956c0f4af6eb764d00dec8080f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c4bba10f0a08d4d0298b00e6c1088ed.webp",980,1306]